The study of prevalence of metabolic syndrome in the first degree relatives of type 2 diabetes mellitus patients

Mahim Mittal, Himanshu Gupta, Deepshikha .


Background: Metabolic syndrome (MetS) is associated with higher incidence of new onset DM. First degree relatives (FDR) of T2DM patients also have an increased risk of new onset DM due to common genetic factors that can lead to obesity and dyslipidemia. Objectives of research work was to study the prevalence of MetS in FDR of T2DM patients.

Methods: Cross-sectional study of FDR of T2DM patients. MetS defined by both IDF and NCEP-ATPIII criteria. All subjects underwent necessary biochemical tests, a detailed history in a pre defined proforma was taken and clinical examination was done as per protocol.

Results: Mean age was 43.61±11.7 years. Prevalence of MetS was 35% by IDF and 25% by NCEP-ATPIII. According to IDF criteria, the most prevalent risk factors among FDR were central obesity and hypertension. Prevalence of MetS was higher in urban, sedentary and obese population.

Conclusions: Prevalence of MetS is more in FDR of T2DM than that reported in the general population. Central obesity is the most prevalent risk factor. Targeted lifestyle intervention in this population may help prevent the development of MetS and T2DM.


First degree relatives, Metabolic syndrome, Type 2 DM

Full Text:



Patel JL, Suthar AM, Dalsaniya VB, Parikh AP, Suthar NN, KL Patel, et al. A study of metabolic syndrome and its components in Type 2 Diabetes Mellitus subjects and their asymptomatic First degree relatives. Indian J Clinical Practice. 2013;23(9):520-33.

Expert Panel on Detection E. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486.

Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53(8):2087-94.

Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28(11):2745-9.

International Diabetes Federation. The IDF concensus worldwide definition of the metabolic syndrome. IDF. 2006:1-2.

Siewert S, Filipuzzi S, Codazzi L, Gonzalez I, Ojeda MS. Impact of metabolic syndrome risk factors in first-degree relatives of type 2 diabetic patients. The review of diabetic studies: RDS. 2007;4(3):177.

Ogedengbe SO, Ezeani IU. Profile of metabolic abnormalities seen in patients with type 2 diabetes mellitus and their first degree relatives with metabolic syndrome seen in Benin City, Edo state Nigeria. J Diab Meta Dis. 2014 Dec;13(1):61.

Janghorbani M, Amini M. Metabolic syndrome in first degree relatives of patients with type 2 diabetes: Incidence and risk factors. Diabetes & Metabolic Syndrome: Clinical Res Rev. 2011 Oct 1;5(4):201-6.

Meis SB, Schuster D, Gaillard T, Osei K. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox. Ethnicity & disease. 2006 Sep 1;16(4):830-6.

Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES‐34). Diabetes/metabolism research and reviews. 2007 Feb;23(2):127-34.

Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Inter J Cardiol. 2004 Nov 1;97(2):257-61.

Denke MA, Sempos CT, Grundy SM. Excess body weight. An under recognized contributor to high blood cholesterol levels in white American men. Arch intern Med. 1993;153(9):1093-1103.

Eckel RH. Obesity: mechanisms and clinical management. Lippincott Williams and Wilkins, Philadelphia, 2003;307-E/2003-03.

McKeique PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337(8738):382-6.

Enas EA, Mohan V, Deepa M, Farooq S, Pazhoor S, Chennikkara H. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. J Cardiometabolic Syndrome. 2007 Sep;2(4):267-75.

Reddy KS, Satija A. The Framingham heart study: impact on the prevention and control of cardiovascular diseases in India. Prog Cardiovasc Dis. 2010;53(1):21-7.

Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Inter J Obesity. 2001 Nov;25(11):1722.

Misra A, Sharma R, Pandey RM, Khanna N. Adverse profile of dietary nutrients, anthropometry and lipids in urban slum dwellers of northern India. Euro J Clinical Nutrition. 2001 Sep;55(9):727.